Avanir Pharmaceuticals (United States)

Avanir Pharmaceuticals (United States)

Open Access statistics for Avanir Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2024.

Open Access statistics for Avanir Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

46%


Total
Publications

176


Total Open
Publications

81


Total
Citations

3.6K


Open Access
Percentage

46%


Total
Publications

176


Total Open
Publications

81


Total
Citations

3.6K

Website

download

Breakdown

31% 11% 4% 54%

Publisher Open

31%

Both

11%

Other Platform Open

4%

Closed

54%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416182022242628Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

9%OA Journal

OA Journal 9%

7

Hybrid 35%

26

No Guarantees 56%

42

Other Platform Open

Domain 81%

21

Institution 15%

4

Public 15%

4

Preprint 0%

0

Other Internet 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
20
Europe PMC
Domain
11
University of Westminster - WestminsterResearch
Institution
3
Semantic Scholar
Public
3
Munich University - Munich Personal RePEc Archive
Institution
1
Ludwig Maximilian University of Munich - Munich Personal RePEc Archive
Institution
1
Figshare
Public
1
1 / 1

Data updated 7 April 2025

Share

Share

Share